Authors:
Teraoka, S
Nomoto, K
Mito, M
Yoshinaga, K
Kurokawa, K
Igata, A
Sonoda, T
Orita, K
Fujimi, S
Toma, S
Citation: S. Teraoka et al., Multivariate analyses of factors contributing to early graft function in 759 kidney transplants from non-heart-beating donors, TRANSPLAN P, 33(1-2), 2001, pp. 1125-1126
Authors:
Gochi, A
Orita, K
Fuchimoto, S
Tanaka, N
Ogawa, N
Citation: A. Gochi et al., The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients, BR J CANC, 84(4), 2001, pp. 443-451
Authors:
Nakamura, S
Otani, T
Okura, R
Ijiri, Y
Motoda, R
Kurimoto, M
Orita, K
Citation: S. Nakamura et al., Expression and responsiveness of human interleukin-18 receptor (IL-18R) onhematopoietic cell lines, LEUKEMIA, 14(6), 2000, pp. 1052-1059
Authors:
Iwagaki, H
Tanaka, N
Esato, K
Kaibara, N
Sano, K
Dohi, K
Nakamura, T
Nakasato, H
Orita, K
Citation: H. Iwagaki et al., Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU aloneas postoperative adjuvant chemotherapy for colorectal cancer, ANTICANC R, 20(5C), 2000, pp. 3727-3734
Authors:
Nakamura, S
Otani, T
Ijiri, Y
Motoda, R
Kurimoto, M
Orita, K
Citation: S. Nakamura et al., IFN-gamma-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12, J IMMUNOL, 164(6), 2000, pp. 3330-3336
Authors:
Inoue, T
Kibata, K
Suzuki, M
Nakamura, S
Motoda, R
Orita, K
Citation: T. Inoue et al., Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16, FEBS LETTER, 469(1), 2000, pp. 14-18
Authors:
Matsuo, Y
Drexler, HG
Nishizaki, C
Harashima, A
Fukuda, S
Kozuka, T
Sezaki, T
Orita, K
Citation: Y. Matsuo et al., Human bone marrow stroma-dependent cell line MOLP-5 derived from a patientin leukaemic phase of multiple myeloma, BR J HAEM, 109(1), 2000, pp. 54-63
Authors:
Matsuo, Y
Drexler, HG
Takeuchi, M
Orita, K
Citation: Y. Matsuo et al., Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia, LEUK LYMPH, 35(5-6), 1999, pp. 513
Authors:
Matsuo, Y
Drexler, HG
Takeuchi, M
Orita, K
Citation: Y. Matsuo et al., A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia, LEUK RES, 23(8), 1999, pp. 731-740
Authors:
Matsuo, Y
Sugimoto, A
Harashima, A
Nishizaki, C
Ishimaru, F
Kondo, E
Katayama, Y
Harada, M
Orita, K
Citation: Y. Matsuo et al., Establishment and characterization of a novel ALL-L3 cell line (BALM-18): induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells, LEUK RES, 23(6), 1999, pp. 559-568
Authors:
Matsuo, Y
Sugimoto, A
Kuwahara, K
Watanabe, Y
Sakata, A
Sakaguchi, N
Sagawa, K
Orita, K
Citation: Y. Matsuo et al., Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules, TISSUE ANTI, 52(5), 1998, pp. 422-429